AbbVie Inc.

13D and 13G Filings

13D/G filings
13G on 1 security
Location
North Chicago, IL
CIK
0001551152
Form D filings
1 filing
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13G · 1 security · passive
Xilio Therapeutics, Inc. 13G
XLO · 98422T100
9.0% 2/18/2025
Event 2/11/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.